Episode Details

Pfizer’s Midtown East skyscraper, set to become a 1,600-unit luxury apartment complex, hit a major snag when steel columns buckled, forcing evacuations and triggering an investigation. While developers call it a “freak accident” affecting only a small portion—and note the building isn’t even slated for move-in until next year—they’re betting high demand will erase the blip from tenants’ minds. Real estate insiders argue the hiccup might even benefit nearby developers by slowing market saturation. But with the city’s Department of Buildings probing and potential delays looming, the financial stakes are high—any prolonged fix could strain the project’s timeline and cash flow.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/04ce7d8c182932db